Myasthenic crisis after the cessation of FK506 in a patient with myasthenia gravis

被引：2
作者：
Konishi, T
Sanada, M
Takehana, K
机构：
[1] Natl Utano Hosp, Dept Neurol, Kyoto 6168255, Japan
[2] Shiga Univ Med Sci, Dept Neurol, Div Neurol, Shiga, Japan
[3] Kansai Med Univ, Ctr Cardiovasc, Dept Cardiol, Kansai, Japan
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷 / 09期
关键词：
D O I：
10.1007/s00415-004-0504-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1154 / 1155
页数：2
相关论文
共 11 条
[1]   MEDICAL PROGRESS - MYASTHENIA-GRAVIS [J].
DRACHMAN, DB .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (25) :1797-1810
[2]   Successful treatment of myasthenia gravis with tacrolimus [J].
Evoli, A ;
Di Schino, C ;
Marsili, F ;
Punzi, C .
MUSCLE & NERVE, 2002, 25 (01) :111-114
[3]   MYASTHENIA-GRAVIS - REACTIVATION OF CLINICAL-DISEASE AND OF AUTOIMMUNE FACTORS AFTER DISCONTINUATION OF LONG-TERM AZATHIOPRINE [J].
HOHLFELD, R ;
TOYKA, KV ;
BESINGER, UA ;
GERHOLD, B ;
HEININGER, K .
ANNALS OF NEUROLOGY, 1985, 17 (03) :238-242
[4]   Myasthenia gravis - Recommendations for clinical research standards [J].
Jaretzki, A ;
Barohn, RJ ;
Ernstoff, RM ;
Kaminski, HJ ;
Keesey, JC ;
Penn, AS ;
Sanders, DB .
NEUROLOGY, 2000, 55 (01) :16-23
[5]   FK-506, A NOVEL IMMUNOSUPPRESSANT ISOLATED FROM A STREPTOMYCES .1. FERMENTATION, ISOLATION, AND PHYSICOCHEMICAL AND BIOLOGICAL CHARACTERISTICS [J].
KINO, T ;
HATANAKA, H ;
HASHIMOTO, M ;
NISHIYAMA, M ;
GOTO, T ;
OKUHARA, M ;
KOHSAKA, M ;
AOKI, H ;
IMANAKA, H .
JOURNAL OF ANTIBIOTICS, 1987, 40 (09) :1249-1255
[6]   Clinical study of FK506 in patients with myasthenia gravis [J].
Konishi, T ;
Yoshiyama, Y ;
Takamori, M ;
Yagi, K ;
Mukai, E ;
Saida, T .
MUSCLE & NERVE, 2003, 28 (05) :570-574
[7]   MYASTHENIA-GRAVIS - DISCONTINUATION OF LONG-TERM AZATHIOPRINE [J].
MICHELS, M ;
HOHLFELD, R ;
HARTUNG, HP ;
HEININGER, K ;
BESINGER, UA ;
TOYKA, KV .
ANNALS OF NEUROLOGY, 1988, 24 (06) :798-798
[8]   TRANSCRIPTIONAL INHIBITION OF INSULIN BY FK506 AND POSSIBLE INVOLVEMENT OF FK506 BINDING PROTEIN-12 IN PANCREATIC BETA-CELL [J].
TAMURA, K ;
FUJIMURA, T ;
TSUTSUMI, T ;
NAKAMURA, K ;
OGAWA, T ;
ATUMARU, C ;
HIRANO, Y ;
OHARA, K ;
OHTSUKA, K ;
SHIMOMURA, K ;
KOBAYASHI, M .
TRANSPLANTATION, 1995, 59 (11) :1606-1613
[9]   MODE OF ACTION OF TACROLIMUS (FK506) - MOLECULAR AND CELLULAR MECHANISMS [J].
THOMSON, AW ;
BONHAM, CA ;
ZEEVI, A .
THERAPEUTIC DRUG MONITORING, 1995, 17 (06) :584-591
[10]   Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus [J].
Toyonaga, T ;
Kondo, T ;
Miyamura, N ;
Sekigami, T ;
Sonoda, K ;
Kodama, S ;
Shirakami, A ;
Shirotani, T ;
Araki, E .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2002, 56 (01) :13-18
12